These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31502174)

  • 1. Multiplatform Integrative Analysis of Immunogenomic Data for Biomarker Discovery.
    Thorsson V
    Methods Mol Biol; 2020; 2055():679-698. PubMed ID: 31502174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional Genome Profiling to Understand Cancer Immune Responsiveness.
    Wang E; Bedognetti D; Marincola FM
    Methods Mol Biol; 2020; 2055():231-244. PubMed ID: 31502155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automatically visualise and analyse data on pathways using PathVisioRPC from any programming environment.
    Bohler A; Eijssen LM; van Iersel MP; Leemans C; Willighagen EL; Kutmon M; Jaillard M; Evelo CT
    BMC Bioinformatics; 2015 Aug; 16(1):267. PubMed ID: 26298294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomics-based immuno-oncology: bridging the gap between immunology and tumor biology.
    DiNatale RG; Hakimi AA; Chan TA
    Hum Mol Genet; 2020 Oct; 29(R2):R214-R225. PubMed ID: 33029628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Status of Immune Oncology: Challenges and Opportunities.
    Cesano A; Marincola FM; Thurin M
    Methods Mol Biol; 2020; 2055():3-21. PubMed ID: 31502145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of Cancer Gene Profiling Data.
    Roy J; Winter C; Schroeder M
    Methods Mol Biol; 2016; 1381():211-22. PubMed ID: 26667463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Data Mining Approaches for Genomic Biomarker Development: Applications Using Drug Screening Data from the Cancer Genome Project and the Cancer Cell Line Encyclopedia.
    Covell DG
    PLoS One; 2015; 10(7):e0127433. PubMed ID: 26132924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-scale public data reuse to model immunotherapy response and resistance.
    Fu J; Li K; Zhang W; Wan C; Zhang J; Jiang P; Liu XS
    Genome Med; 2020 Feb; 12(1):21. PubMed ID: 32102694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a prognostic index based on an immunogenomic landscape analysis of papillary thyroid cancer.
    Lin P; Guo YN; Shi L; Li XJ; Yang H; He Y; Li Q; Dang YW; Wei KL; Chen G
    Aging (Albany NY); 2019 Jan; 11(2):480-500. PubMed ID: 30661062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative Analysis of Cancer Omics Data for Prognosis Modeling.
    Wang S; Wu M; Ma S
    Genes (Basel); 2019 Aug; 10(8):. PubMed ID: 31405076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Integrative Approach for Identifying Network Biomarkers of Breast Cancer Subtypes Using Genomic, Interactomic, and Transcriptomic Data.
    Firoozbakht F; Rezaeian I; D'agnillo M; Porter L; Rueda L; Ngom A
    J Comput Biol; 2017 Aug; 24(8):756-766. PubMed ID: 28650678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated genomic profiling expands clinical options for patients with cancer.
    Beaubier N; Bontrager M; Huether R; Igartua C; Lau D; Tell R; Bobe AM; Bush S; Chang AL; Hoskinson DC; Khan AA; Kudalkar E; Leibowitz BD; Lozachmeur A; Michuda J; Parsons J; Perera JF; Salahudeen A; Shah KP; Taxter T; Zhu W; White KP
    Nat Biotechnol; 2019 Nov; 37(11):1351-1360. PubMed ID: 31570899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Gene Expression-Based Biomarkers on the nCounter
    Warren S; Danaher P; Mashadi-Hossein A; Skewis L; Wallden B; Ferree S; Cesano A
    Methods Mol Biol; 2020; 2055():273-300. PubMed ID: 31502157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR screen in mechanism and target discovery for cancer immunotherapy.
    Liu D; Zhao X; Tang A; Xu X; Liu S; Zha L; Ma W; Zheng J; Shi M
    Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188378. PubMed ID: 32413572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer genomics identifies determinants of tumor biology.
    Mardis ER
    Genome Biol; 2010; 11(5):211. PubMed ID: 20441611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of cancer genomics with treatment selection: from the genome to predictive biomarkers.
    Ow TJ; Sandulache VC; Skinner HD; Myers JN
    Cancer; 2013 Nov; 119(22):3914-28. PubMed ID: 24037788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NOJAH: NOt Just Another Heatmap for genome-wide cluster analysis.
    Rupji M; Dwivedi B; Kowalski J
    PLoS One; 2019; 14(3):e0204542. PubMed ID: 30921318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Integrative Method Based on the Module-Network for Identifying Driver Genes in Cancer Subtypes.
    Lu X; Li X; Liu P; Qian X; Miao Q; Peng S
    Molecules; 2018 Jan; 23(2):. PubMed ID: 29364829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-omics in high-grade serous ovarian cancer: Biomarkers from genome to the immunome.
    Clifford C; Vitkin N; Nersesian S; Reid-Schachter G; Francis JA; Koti M
    Am J Reprod Immunol; 2018 Aug; 80(2):e12975. PubMed ID: 29781548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preface on application of omics technologies in cancer biology and therapy.
    Georgakilas AG
    Cancer Lett; 2016 Nov; 382(1):A1. PubMed ID: 27765153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.